Methadone for Cancer-Related Neuropathic Pain
Author Information
Author(s): Ragaban Faten, Purohit Om, Del Fabbro Egidio
Primary Institution: Medical College of Georgia, Augusta University
Hypothesis
Can methadone be an effective first-line treatment for cancer-related neuropathic pain?
Conclusion
Methadone may be a more effective choice than other opioids for managing cancer-related neuropathic pain.
Supporting Evidence
- Studies indicate methadone provides superior pain relief compared to morphine.
- Patients switching to methadone reported significant pain relief.
- Combination therapy with methadone and duloxetine showed improved outcomes.
Takeaway
Methadone can help people with cancer pain feel better, especially when other treatments don't work.
Methodology
A narrative review based on a comprehensive literature search from 2000 to 2024, focusing on studies evaluating methadone's efficacy in cancer-related neuropathic pain.
Potential Biases
Single-blind design and small sample sizes may introduce bias.
Limitations
Limited high-quality studies and potential biases in included trials.
Participant Demographics
Patients with cancer experiencing neuropathic pain, including those with mixed nociceptive-neuropathic pain.
Statistical Information
P-Value
0.0421
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website